Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients

BACKGROUND: The treatment of metastatic breast cancer (MBC) remains a great clinical challenge as drug resistance frequently develops. Alternative agents that can overcome drug resistance would offer new therapeutic options. The primary aim of this phase II study was to evaluate the efficacy and saf...

Full description

Saved in:
Bibliographic Details
Published in:J Hematol Oncol
Main Authors: Zhang, Pin, Tong, Zhongsheng, Tian, Fuguo, Wang, Yongsheng, Yang, Junlan, Li, Weilian, Di, Lijun, Liu, Wei, Tang, Li, Qiu, Rongguo, Xu, Binghe
Format: Artigo
Language:Inglês
Published: BioMed Central 2016
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4982136/
https://ncbi.nlm.nih.gov/pubmed/27516093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-016-0297-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items